宜明昂科生物医药技术（上海）股份有限公司（股票名称：宜明昂科-B，股票代码：01541）于2026年7月8日公告，开展股份购回，回购数量为55,600股，占当时已发行股本的约0.0133%。回购价格区间介乎每股3.58港元至3.67港元，合计耗资约20.14万港元。
本次购回完成后，公司已发行股本为418,754,305股，库藏股数量增至1,723,000股。公司于2026年5月28日获得购回授权，总授权购回数量为43,150,769股，截至目前累计已回购1,723,000股，占授权通过当日已发行股本的约0.399%。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由执行董事、联席公司秘书关梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.